
Illumina to divest cancer test maker Grail if it loses US or EU court appeal
Illumina to divest cancer test maker Grail if it loses US or EU court appeal (Reuters) -Illumina Inc...
12th October, 2023

Illumina to divest cancer test maker Grail if it loses US or EU court appeal (Reuters) -Illumina Inc...
12th October, 2023

ERC fraud and how to avoid it By Brock Blake, CEO of Lendio The Employee Retention Tax Credit (ERC o...
11th October, 2023

HP forecasts 2024 profit in line with estimates, boosts annual dividend (Reuters) -HP Inc on Tuesday...
11th October, 2023

Court OKs Mallinckrodt restructuring, $1 billion cut to opioid settlement By Dietrich Knauth (Reuter...
11th October, 2023

Personal finance apps In 2023, personal finance management has never been more crucial, with individ...
10th October, 2023

Analysis-Is the US strategy of engaging China working? By Michael Martina and Humeyra Pamuk WASHINGT...
6th October, 2023

Why International Banking in Belize is a Secure Haven for Global Investors By Luigi Wewege, Presiden...
6th October, 2023

US FDA still not satisfied with Philips recall; stock falls over 9% By Toby Sterling and Piotr Lipin...
6th October, 2023

UK’s J D Wetherspoon posts higher sales on resilient demand (Reuters) -British pub group J D Wethers...
6th October, 2023

Norway plans resource tax on onshore wind farms OSLO (Reuters) – Norway will introduce a resource re...
6th October, 2023

Finnair to raise $632 million to shore up finances STOCKHOLM (Reuters) -Finnish airline Finnair said...
6th October, 2023

The Rising Threat: BEC and Sekur’s Solution BEC, or business email compromise, is among today’s wors...
5th October, 2023